NCT00935467View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics Study of Saxagliptin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Saxagliptin

Tablets, oral, 2.5 mg, twice daily, 7 days

Trial Locations (1)

78744

Ppd Development, Lp, Austin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY